Melanoma detection enhanced with blood biomarkers

May 13, 2014 by Chris Thomas
More than 12,500 new cases of melanoma are diagnosed in Australia annually, making it the third most common form of cancer in Australian men and women. Credit: Ho John Lee

The need for invasive skin biopsies could be reduced extensively with Edith Cowan University researchers working on ways to detect melanoma in early stages, using a blood test in conjunction with visual scans.

A $450,000 National Health and Medical Research Council development grant has enabled them to expand on a 2012 preliminary investigation of 40 people that identified eight blood biomarkers that indicated the early presence of melanoma tumour.

ECU School of Medical Sciences Professor Mel Ziman conducted the original investigation and is working with PhD student Pauline Zaenker and postdoctoral research fellow Dr Elin Gray on the latest study.

Melanoma causes 80 per cent of skin cancer-related deaths with Australia having the highest incidence of melanoma in the world, according to the Melanoma Institute Australia.

More than 12,500 new cases of melanoma are diagnosed in Australia annually, making it the third most common form of cancer in Australian men and women.

Search for diagnostic markers turns to auto-antibodies

In 2012, Prof Zilman's investigation looked for circulating tumour cells as prognostic markers while the current research is assessing auto-antibodies as early diagnostic markers.

"No other researchers have looked for auto-antibodies in serum for diagnostic markers," she says.

"Using an array of more than 1600 protein antigens makes this particularly novel.

"Auto-antibodies are produced by the body in response to the presence of cancerous proteins.

"They were determined using serum from patients placed on an array of antigens extracted from cancerous cells and individually attached to an array."

Previously, increases in serum levels of certain auto-antibodies have been shown to precede the development of disease symptoms and correlate with the incidence of breast, lung, small cell lung, colon, ovary, prostate and head and neck cancers.

Survival rates high with early diagnosis

Prof Zilman says the chance of a patient surviving melanoma is as high as 98 per cent if caught and removed before it has a chance to spread.

"Early diagnosis is the key to improving survival rates," she says. "A reliable could be used to screen at-risk patients annually, reducing the need for unnecessary surgical procedures."

The latest study will involve 300 people—and the research team is looking for volunteers.

Participants need to have been diagnosed with melanoma within the past three months. Healthy volunteers are also needed as age-matched controls (they could possibly be partners of those diagnosed with ).

Explore further: A method for the diagnosis and prognosis of melanoma, the most aggressive skin cancer, is patented

More information: "Serologic autoantibodies as diagnostic cancer biomarkers—a review." Zaenker P., et al. Cancer Epidemiol Biomarkers Prev. 2013 Dec;22(12):2161-81. DOI: 10.1158/1055-9965.EPI-13-0621. Epub 2013 Sep 20.

Related Stories

A method for the diagnosis and prognosis of melanoma, the most aggressive skin cancer, is patented

February 19, 2014
UPV/EHU researchers have developed a method for the diagnosis and prognosis of cutaneous melanoma, the type of skin cancer with the highest mortality rate.This method will help not only in the more effective early detection ...

Higher risk of death from skin cancer among men living alone

April 1, 2014
There are differences in prognosis in cutaneous malignant melanoma depending on cohabitation status and gender, according to a new study published in the scientific periodical Journal of Clinical Oncology. Single men of all ...

Survival hope for melanoma patients thanks to new vaccine

April 17, 2014
(Medical Xpress)—University of Adelaide researchers have discovered that a new trial vaccine offers the most promising treatment to date for melanoma that has spread, with increased patient survival rates and improved ability ...

Lower education linked to premature death from malignant skin melanoma

April 16, 2013
There are socioeconomic differences in Sweden in survival amongst people with malignant skin melanoma, according to a new study published in the European Journal of Cancer. Melanoma patients with a lower educational background ...

Exact outline of melanoma could lead to new diagnostic tools, therapies

May 8, 2014
Researchers at Oregon State University have identified a specific biochemical process that can cause normal and healthy skin cells to transform into cancerous melanoma cells, which should help predict melanoma vulnerability ...

Dermatologist care tied to better self-detection of melanoma

April 25, 2014
(HealthDay)—Patients with self-detected primary melanoma who have an established dermatologist are more likely to have thinner lesions at the time of diagnosis, according to research published in the May issue of the Journal ...

Recommended for you

Anti-cancer chemotherapeutic agent inhibits glioblastoma growth and radiation resistance

July 24, 2017
Glioblastoma is a primary brain tumor with dismal survival rates, even after treatment with surgery, chemotherapy and radiation. A small subpopulation of tumor cells—glioma stem cells—is responsible for glioblastoma's ...

New therapeutic approach for difficult-to-treat subtype of ovarian cancer identified

July 24, 2017
A potential new therapeutic strategy for a difficult-to-treat form of ovarian cancer has been discovered by Wistar scientists. The findings were published online in Nature Cell Biology.

Immune cells the missing ingredient in new bladder cancer treatment

July 24, 2017
New research offers a possible explanation for why a new type of cancer treatment hasn't been working as expected against bladder cancer.

Shooting the achilles heel of nervous system cancers

July 20, 2017
Virtually all cancer treatments used today also damage normal cells, causing the toxic side effects associated with cancer treatment. A cooperative research team led by researchers at Dartmouth's Norris Cotton Cancer Center ...

Molecular changes with age in normal breast tissue are linked to cancer-related changes

July 20, 2017
Several known factors are associated with a higher risk of breast cancer including increasing age, being overweight after menopause, alcohol intake, and family history. However, the underlying biologic mechanisms through ...

Immune-cell numbers predict response to combination immunotherapy in melanoma

July 20, 2017
Whether a melanoma patient will better respond to a single immunotherapy drug or two in combination depends on the abundance of certain white blood cells within their tumors, according to a new study conducted by UC San Francisco ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.